0 ITEMSView cart
Impurities, Tofacitinib ImpuritiesTofacitinib
CAS No. : 477600-75-2 Mol F. : C16H20N6O Mol W. : 312.37 Cat No. : SA43300 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Citrate
CAS No. : 540737-29-9 Mol F. : C22H28N6O8 Mol W. : 504.49 Cat No. : SA43301 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib (3S,4S)-Isomer
CAS No. : 1092578-47-6 (base); 2174011-55-1 (citrate salt) Mol F. : C16H20N6O (base) Mol W. : 312.37 Cat No. : SA43302 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Benzyl Impurity
CAS No. : 477600-73-0 Mol F. : C20H25N5 Mol W. : 335.45 Cat No. : SA43303 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib N-Oxide
CAS No. : 2028267-73-2 Mol F. : C16H20N6O2 Mol W. : 328.37 Cat No. : SA43304 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Dihydro Impurity
CAS No. : 1640972-35-5 Mol F. : C16H22N6O Mol W. : 314.39 Cat No. : SA43305 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Amine impurity
CAS No. : 477600-74-1 (Base); 1260590-51-9 (HCl); 1655430-59-3 (2HCl) Mol F. : C13H19N5 Mol W. : 245.32 Cat No. : SA43306 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Impurity B
CAS No. : 1092578-48-7 Mol F. : C16H20N6O Mol W. : 312.37 Cat No. : SA43307 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Impurity A
CAS No. : 1092578-46-5 Mol F. : C16H20N6O Mol W. : 312.37 Cat No. : SA43308 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacatinib Nitril N-Oxide impurity
CAS No. : NA Mol F. : C16H20N6O2 Mol W. : 328.38 Cat No. : SA43309 Please Enquire
Impurities, Tofacitinib ImpuritiesEthyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CAS No. : 1675248-18-6 Mol F. : C18H25N5O3 Mol W. : 359.43 Cat No. : SA43310 Please Enquire
Impurities, Tofacitinib Impurities2-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-2-oxoacetic acid
CAS No. : NA Mol F. : C15H19N5O3 Mol W. : 317.34 Cat No. : SA43311 Please Enquire
Impurities, Tofacitinib Impurities(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile L-aspartate
CAS No. : NA Mol F. : C20H27N7O5 Mol W. : 445.47 Cat No. : SA43312 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib 5-Oxo Impurity
CAS No. : 2101951-20-4 Mol F. : C16H20N6O2 Mol W. : 328.4 Cat No. : SA43313 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Impurity K
CAS No. : 2328165-36-0 Mol F. : C16H21N5O3 Mol W. : 331.4 Cat No. : SA43314 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib impurity L
CAS No. : 1675248-19-7 Mol F. : C16H22N6O2 Mol W. : 330.38 Cat No. : SA43315 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib N-formyl Impurity
CAS No. : 2227199-28-0 Mol F. : C14H19N5O Mol W. : 273.33 Cat No. : SA43316 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Impurity S
CAS No. : 923036-30-0 Mol F. : C27H31N5O2S Mol W. : 489.6 Cat No. : SA43317 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Trans Impurity
CAS No. : NA Mol F. : C16H20N6O Mol W. : 312.4 Cat No. : SA43318 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib Related Compound 11
CAS No. : 1640971-60-3 Mol F. : C14H20N6O Mol W. : 288.4 Cat No. : SA43319 Please Enquire
Impurities, Tofacitinib Impurities(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
CAS No. : 1062580-52-2 (2HCl) Mol F. : C14H24Cl2N2 Mol W. : 291.26 Cat No. : SA43320 Please Enquire
Impurities, Tofacitinib Impurities6-Chloro-7-Deazapurine
CAS No. : 3680-69-1 (Base) Mol F. : C6H4ClN3 Mol W. : 153.57 Cat No. : SA43321 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib N-Nitroso Impurity 1
CAS No. : NA Mol F. : C16H19N7O2 Mol W. : 341.37 Cat No. : SA43322 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib N-Nitroso Impurity 2
CAS No. : NA Mol F. : C15H17N7O2 Mol W. : 327.34 Cat No. : SA43323 Please Enquire
Impurities, Tofacitinib ImpuritiesTofacitinib N-Nitroso Impurity 3
CAS No. : NA Mol F. : C13H18N6O2 Mol W. : 274.32 Cat No. : SA43324 Please Enquire
